JP2008525311A - 真菌由来の免疫調節性化合物 - Google Patents

真菌由来の免疫調節性化合物 Download PDF

Info

Publication number
JP2008525311A
JP2008525311A JP2007520666A JP2007520666A JP2008525311A JP 2008525311 A JP2008525311 A JP 2008525311A JP 2007520666 A JP2007520666 A JP 2007520666A JP 2007520666 A JP2007520666 A JP 2007520666A JP 2008525311 A JP2008525311 A JP 2008525311A
Authority
JP
Japan
Prior art keywords
composition
polysaccharide
glucose
parts
mannose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007520666A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008525311A5 (fr
Inventor
ビョルン クリステンセン，
Original Assignee
メディマシュ アー／エス
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/892,393 external-priority patent/US7514085B2/en
Application filed by メディマシュ アー／エス filed Critical メディマシュ アー／エス
Publication of JP2008525311A publication Critical patent/JP2008525311A/ja
Publication of JP2008525311A5 publication Critical patent/JP2008525311A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/08—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis for Pneumocystis carinii
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
JP2007520666A 2004-07-16 2005-07-15 真菌由来の免疫調節性化合物 Pending JP2008525311A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US10/892,393 US7514085B2 (en) 2004-07-16 2004-07-16 Immune modulating compounds from fungi
US69047705P 2005-06-15 2005-06-15
US69049605P 2005-06-15 2005-06-15
US69048205P 2005-06-15 2005-06-15
DKPA200500882 2005-06-15
DKPA200500881 2005-06-15
DKPA200500880 2005-06-15
PCT/DK2005/000498 WO2006007848A2 (fr) 2004-07-16 2005-07-15 Composes a modulation immunitaire issus de champignons

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011233448A Division JP5502830B2 (ja) 2004-07-16 2011-10-24 真菌由来の免疫調節性化合物

Publications (2)

Publication Number Publication Date
JP2008525311A true JP2008525311A (ja) 2008-07-17
JP2008525311A5 JP2008525311A5 (fr) 2008-10-02

Family

ID=35414957

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007520666A Pending JP2008525311A (ja) 2004-07-16 2005-07-15 真菌由来の免疫調節性化合物
JP2011233448A Active JP5502830B2 (ja) 2004-07-16 2011-10-24 真菌由来の免疫調節性化合物
JP2013214807A Expired - Fee Related JP5926226B2 (ja) 2004-07-16 2013-10-15 真菌由来の免疫調節性化合物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011233448A Active JP5502830B2 (ja) 2004-07-16 2011-10-24 真菌由来の免疫調節性化合物
JP2013214807A Expired - Fee Related JP5926226B2 (ja) 2004-07-16 2013-10-15 真菌由来の免疫調節性化合物

Country Status (8)

Country Link
EP (1) EP1774012A2 (fr)
JP (3) JP2008525311A (fr)
KR (1) KR20070057803A (fr)
AU (1) AU2005263329A1 (fr)
CA (1) CA2574060C (fr)
IL (1) IL180713A0 (fr)
TW (1) TW200607863A (fr)
WO (1) WO2006007848A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014256D0 (no) 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
WO2006133707A2 (fr) * 2005-06-15 2006-12-21 Medimush A/S Polytherapie contre le cancer et kit de composants associe
EP1896601A1 (fr) * 2005-06-15 2008-03-12 Medimush A/S Agents bio-actifs produits par culture immergee de cellule de basidiomycete
KR100825119B1 (ko) * 2006-12-29 2008-04-25 영남대학교 산학협력단 간질환의 예방 또는 치료용 약학조성물
WO2010130036A1 (fr) * 2009-05-15 2010-11-18 Her Majesty The Queen In Right Of The Province Of Nova Scotia, As Represented By The Nova Scotia Agricultural College (Nsac) On Behalf Of The Minister Of Agriculture Compositions de boissons fonctionnelles stables et leurs procédés de fabrication
KR101695488B1 (ko) * 2013-12-06 2017-01-23 한명순 설사 예방 및 개선용 조성물 및 이를 이용한 경구용 주사기 패키지
WO2015083982A1 (fr) * 2013-12-06 2015-06-11 한명순 Composition pour prévenir la diarrhée et améliorer son traitement et emballage de seringue orale l'utilisant
EP3244905A4 (fr) 2015-01-18 2018-12-12 Gavish-Galilee Bio Applications Ltd Extraits de champignons comestibles enrichis en vitamine d et compositions associées, et leur utilisation dans le traitement de troubles liés au système immunitaire
WO2017201615A1 (fr) * 2016-05-23 2017-11-30 Orphaderm Limited Compositions biophotoniques comprenant un chromophore d'origine fongique
KR20180093725A (ko) 2017-02-14 2018-08-22 강원대학교산학협력단 렌티난을 함유하는 패혈증의 치료 또는 개선용 약학적 조성물
CN108410944A (zh) * 2018-06-05 2018-08-17 郑州安图生物工程股份有限公司 一种检测艰难梭菌用培养基及其制备方法
TWI673058B (zh) * 2018-07-20 2019-10-01 金穎生物科技股份有限公司 靈芝複合多醣體組成物
CN110403962A (zh) * 2019-09-04 2019-11-05 湖南宇山玉月农业科技有限公司 一种真菌植物在防治鸡坏死性肠炎的应用
CN110656053B (zh) * 2019-11-01 2021-04-13 广东省微生物研究所（广东省微生物分析检测中心） 一种鳞伞属新菌种及其人工栽培方法和用途
FI130808B1 (fi) * 2021-02-19 2024-03-27 Natural Resources Inst Finland Luke Sieniperäinen koostumus, sen tuotantomenetelmä ja käytöt
IT202100029000A1 (it) 2021-11-16 2023-05-16 C I A M S R L Composizioni immunostimolanti per animali da compagnia

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02145601A (ja) * 1988-11-28 1990-06-05 Ajinomoto Co Inc カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法
WO2003020944A2 (fr) * 2001-09-03 2003-03-13 Medimush Aps Production de composes fongiques immunostimulants extracellulaires

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1572074A (en) * 1977-03-30 1980-07-23 Kirin Seagram Ltd Chemotherapeutic substances and methods of manufacturing same
JPS54148702A (en) * 1978-05-12 1979-11-21 Kirin Brewery Kss22b
JPS5653101A (en) * 1979-09-21 1981-05-12 Kirin Brewery Co Ltd Polysaccharide ks-2-d and its preparation
JPH0757761B2 (ja) * 1984-03-08 1995-06-21 株式会社林原生物化学研究所 β−グルカンとその製造方法及び用途
EP0292601A1 (fr) * 1987-05-14 1988-11-30 Noda Shokukin Kogyo Co., Ltd. Médicaments contre le sida extrait de lentinus edodes
FR2631829B1 (fr) * 1988-05-30 1992-04-03 Pasteur Institut Exopolysaccharides fongiques ayant une activite immunostimulante, leur procede d'obtention et composition therapeutique les contenant
JP3522772B2 (ja) * 1991-05-21 2004-04-26 台糖株式会社 ワクチンの免疫効果増強剤
JP3651697B2 (ja) * 1995-03-24 2005-05-25 株式会社アミノアップ化学 新規多糖体物質
CN1069650C (zh) * 1995-12-29 2001-08-15 中国科学院上海药物研究所 香菇多糖的分离纯化方法
AU6261999A (en) * 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
CA2538218C (fr) * 2003-09-08 2014-11-25 Genyous Biomed International Inc. Compositions d'extraits botaniques utilisees dans la therapie cancereuse

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02145601A (ja) * 1988-11-28 1990-06-05 Ajinomoto Co Inc カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法
WO2003020944A2 (fr) * 2001-09-03 2003-03-13 Medimush Aps Production de composes fongiques immunostimulants extracellulaires

Also Published As

Publication number Publication date
AU2005263329A1 (en) 2006-01-26
TW200607863A (en) 2006-03-01
CA2574060A1 (fr) 2006-01-26
WO2006007848A3 (fr) 2006-02-23
EP1774012A2 (fr) 2007-04-18
WO2006007848A2 (fr) 2006-01-26
IL180713A0 (en) 2007-06-03
JP5502830B2 (ja) 2014-05-28
JP2012017347A (ja) 2012-01-26
JP5926226B2 (ja) 2016-05-25
KR20070057803A (ko) 2007-06-07
JP2014005307A (ja) 2014-01-16
CA2574060C (fr) 2019-06-25

Similar Documents

Publication Publication Date Title
JP5926226B2 (ja) 真菌由来の免疫調節性化合物
US7682615B2 (en) Immune modulating compounds from fungi
JP6349405B2 (ja) 抗炎症剤
US20100086647A1 (en) Feed or food products comprising fungal material
KR101234435B1 (ko) 면역 부활용 조성물
US20090005340A1 (en) Bioactive Agents Produced By Submerged Cultivation of a Basidiomycete Cell
KR101640744B1 (ko) 고분자 다당 바인더에 컨쥬게이트된 락토바실러스 람노서스 rht-3201, 및 이의 아토피 예방 및 치료 용도
TW201021816A (en) Composition comprising a combination of an elder extract and a strain of L. paracasei, L. casei, L. bulgaricus or S. thermophilus
TW201919657A (zh) 提昇免疫之組合物及方法
WO2011099875A1 (fr) Utilisation de bactéries lactiques pour traiter ou prévenir la rhinite
KR102500796B1 (ko) 케피어 유래 유산균의 세포표면단백질을 포함하는 비만의 예방 또는 치료용 조성물
JP6999061B1 (ja) 免疫賦活用組成物、風邪様症状予防剤、及びウイルス感染予防剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080714

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080714

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080806

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110425

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110713

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110721

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111024

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20120312